BioSpace News Archive

Galvanize announced that it received U.S. Food and Drug Administration 510 regulatory clearance for the INUMI Flex endoscopic needle for use with the Aliya® PEF System for soft tissue ablation.

Ionis Pharmaceuticals, Inc. announced that it will host a live webcast on Friday, May 31th at 8:00 a.m. Eastern Time to discuss the donidalorsen Phase 3 OASIS-HAE and OASISplus study results that will be presented in three late-breaking oral presentations at the 2024 European Academy of Allergy and Clinical Immunology Annual Meeting in Valencia, Spain.

BioLineRx Ltd. reported its unaudited financial results for the first quarter ended March 31, 2024, and provided recent corporate and portfolio updates.

Alkermes plc announced plans to present three posters related to ALKS 2680 at SLEEP 2024, the 38th annual meeting of the Associated Professional Sleep Societies, taking place June 1-5, 2024 in Houston.

Remix Therapeutics announced that its management team will host one-on-one meetings with investors at the Jefferies Healthcare Conference taking place on Tuesday, June 4, 2024 in New York City.

Turn Biotechnologies announced an exclusive global licensing agreement with pharmaceutical manufacturer HanAll Biopharma to develop groundbreaking medicines for the treatment of age-related eye and ear conditions.

Cartography Biosciences, Inc., announced that it has entered into a strategic collaboration agreement with Gilead Sciences, Inc., to discover and develop therapies for patients with triple-negative breast cancer and the most common form of non-small cell lung cancer, adenocarcinoma.

Asahi Kasei Corp. announces that it will offer the shareholders of Calliditas Therapeutics AB to acquire the shares of the pharmaceutical company Calliditas for the purpose of making Calliditas a wholly-owned subsidiary of Asahi Kasei through a voluntary tender offer for Calliditas.

Septerna today announced that management will participate in the Jefferies Global Healthcare Conference in New York on Tuesday, June 4, 2024.

Bausch + Lomb Corporation, a leading global eye health company dedicated to helping people see better to live better, announced that Health Canada has approved the enVista® Envy™* full visual range intraocular lens.